DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR.
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Lancet 2006;
368: 1096-1105
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.